The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cord Blood Registry Market Research Report 2024

Global Cord Blood Registry Market Research Report 2024

Publishing Date : Sep, 2023

License Type :
 

Report Code : 1791618

No of Pages : 108

Synopsis
Stem Cell Banking refers to the human stem cell transplantation for the purpose, with acquisition, processing, preservation and provides the ability to differentiate stem cell storage bank, has been called the "life bank".
Global Cord Blood Registry market is projected to reach US$ 2374.4 million in 2029, increasing from US$ 1500 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cord Blood Registry market research.
The stem cell storage service market is primarily driven by the increasing recognition of stem cells' therapeutic potential and the growing demand for personalized and regenerative medicine. Stem cell storage services offer the option to collect and preserve stem cells from various sources, such as umbilical cord blood, adipose tissue, and dental pulp, for future medical use. The rising prevalence of chronic diseases and the need for novel treatments propel the adoption of stem cell storage, as these cells hold promise for regenerating damaged tissues and organs. However, the market also faces challenges, including ethical considerations related to the commercialization of stem cells and the lack of standardized guidelines for stem cell banking and storage. Ensuring the quality and viability of stored stem cells throughout the storage period is critical, and stringent regulatory oversight is required to address safety concerns and maintain public trust in stem cell storage services.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cord Blood Registry market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
CCBC
CBR
ViaCord
Esperite
Vcanbio
Boyalife
LifeCell
Crioestaminal
RMS Regrow
Cryo-cell
Cordlife Group
PBKM FamiCord
cells4life
Beikebiotech
StemCyte
Cellsafe Biotech Group
PacifiCord
Americord
Krio
Familycord
Cryo Stemcell
Stemade Biotech
Segment by Type
Umbilical Cord Blood Stem Cell
Embryonic Stem Cell
Adult Stem Cell
Other
Segment by Application
Diseases Therapy
Healthcare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cord Blood Registry report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cord Blood Registry Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Umbilical Cord Blood Stem Cell
1.2.3 Embryonic Stem Cell
1.2.4 Adult Stem Cell
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cord Blood Registry Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diseases Therapy
1.3.3 Healthcare
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cord Blood Registry Market Perspective (2018-2029)
2.2 Cord Blood Registry Growth Trends by Region
2.2.1 Global Cord Blood Registry Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cord Blood Registry Historic Market Size by Region (2018-2023)
2.2.3 Cord Blood Registry Forecasted Market Size by Region (2024-2029)
2.3 Cord Blood Registry Market Dynamics
2.3.1 Cord Blood Registry Industry Trends
2.3.2 Cord Blood Registry Market Drivers
2.3.3 Cord Blood Registry Market Challenges
2.3.4 Cord Blood Registry Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cord Blood Registry Players by Revenue
3.1.1 Global Top Cord Blood Registry Players by Revenue (2018-2023)
3.1.2 Global Cord Blood Registry Revenue Market Share by Players (2018-2023)
3.2 Global Cord Blood Registry Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cord Blood Registry Revenue
3.4 Global Cord Blood Registry Market Concentration Ratio
3.4.1 Global Cord Blood Registry Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cord Blood Registry Revenue in 2022
3.5 Cord Blood Registry Key Players Head office and Area Served
3.6 Key Players Cord Blood Registry Product Solution and Service
3.7 Date of Enter into Cord Blood Registry Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cord Blood Registry Breakdown Data by Type
4.1 Global Cord Blood Registry Historic Market Size by Type (2018-2023)
4.2 Global Cord Blood Registry Forecasted Market Size by Type (2024-2029)
5 Cord Blood Registry Breakdown Data by Application
5.1 Global Cord Blood Registry Historic Market Size by Application (2018-2023)
5.2 Global Cord Blood Registry Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cord Blood Registry Market Size (2018-2029)
6.2 North America Cord Blood Registry Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cord Blood Registry Market Size by Country (2018-2023)
6.4 North America Cord Blood Registry Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cord Blood Registry Market Size (2018-2029)
7.2 Europe Cord Blood Registry Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cord Blood Registry Market Size by Country (2018-2023)
7.4 Europe Cord Blood Registry Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cord Blood Registry Market Size (2018-2029)
8.2 Asia-Pacific Cord Blood Registry Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cord Blood Registry Market Size by Region (2018-2023)
8.4 Asia-Pacific Cord Blood Registry Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cord Blood Registry Market Size (2018-2029)
9.2 Latin America Cord Blood Registry Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cord Blood Registry Market Size by Country (2018-2023)
9.4 Latin America Cord Blood Registry Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cord Blood Registry Market Size (2018-2029)
10.2 Middle East & Africa Cord Blood Registry Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cord Blood Registry Market Size by Country (2018-2023)
10.4 Middle East & Africa Cord Blood Registry Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CCBC
11.1.1 CCBC Company Detail
11.1.2 CCBC Business Overview
11.1.3 CCBC Cord Blood Registry Introduction
11.1.4 CCBC Revenue in Cord Blood Registry Business (2018-2023)
11.1.5 CCBC Recent Development
11.2 CBR
11.2.1 CBR Company Detail
11.2.2 CBR Business Overview
11.2.3 CBR Cord Blood Registry Introduction
11.2.4 CBR Revenue in Cord Blood Registry Business (2018-2023)
11.2.5 CBR Recent Development
11.3 ViaCord
11.3.1 ViaCord Company Detail
11.3.2 ViaCord Business Overview
11.3.3 ViaCord Cord Blood Registry Introduction
11.3.4 ViaCord Revenue in Cord Blood Registry Business (2018-2023)
11.3.5 ViaCord Recent Development
11.4 Esperite
11.4.1 Esperite Company Detail
11.4.2 Esperite Business Overview
11.4.3 Esperite Cord Blood Registry Introduction
11.4.4 Esperite Revenue in Cord Blood Registry Business (2018-2023)
11.4.5 Esperite Recent Development
11.5 Vcanbio
11.5.1 Vcanbio Company Detail
11.5.2 Vcanbio Business Overview
11.5.3 Vcanbio Cord Blood Registry Introduction
11.5.4 Vcanbio Revenue in Cord Blood Registry Business (2018-2023)
11.5.5 Vcanbio Recent Development
11.6 Boyalife
11.6.1 Boyalife Company Detail
11.6.2 Boyalife Business Overview
11.6.3 Boyalife Cord Blood Registry Introduction
11.6.4 Boyalife Revenue in Cord Blood Registry Business (2018-2023)
11.6.5 Boyalife Recent Development
11.7 LifeCell
11.7.1 LifeCell Company Detail
11.7.2 LifeCell Business Overview
11.7.3 LifeCell Cord Blood Registry Introduction
11.7.4 LifeCell Revenue in Cord Blood Registry Business (2018-2023)
11.7.5 LifeCell Recent Development
11.8 Crioestaminal
11.8.1 Crioestaminal Company Detail
11.8.2 Crioestaminal Business Overview
11.8.3 Crioestaminal Cord Blood Registry Introduction
11.8.4 Crioestaminal Revenue in Cord Blood Registry Business (2018-2023)
11.8.5 Crioestaminal Recent Development
11.9 RMS Regrow
11.9.1 RMS Regrow Company Detail
11.9.2 RMS Regrow Business Overview
11.9.3 RMS Regrow Cord Blood Registry Introduction
11.9.4 RMS Regrow Revenue in Cord Blood Registry Business (2018-2023)
11.9.5 RMS Regrow Recent Development
11.10 Cryo-cell
11.10.1 Cryo-cell Company Detail
11.10.2 Cryo-cell Business Overview
11.10.3 Cryo-cell Cord Blood Registry Introduction
11.10.4 Cryo-cell Revenue in Cord Blood Registry Business (2018-2023)
11.10.5 Cryo-cell Recent Development
11.11 Cordlife Group
11.11.1 Cordlife Group Company Detail
11.11.2 Cordlife Group Business Overview
11.11.3 Cordlife Group Cord Blood Registry Introduction
11.11.4 Cordlife Group Revenue in Cord Blood Registry Business (2018-2023)
11.11.5 Cordlife Group Recent Development
11.12 PBKM FamiCord
11.12.1 PBKM FamiCord Company Detail
11.12.2 PBKM FamiCord Business Overview
11.12.3 PBKM FamiCord Cord Blood Registry Introduction
11.12.4 PBKM FamiCord Revenue in Cord Blood Registry Business (2018-2023)
11.12.5 PBKM FamiCord Recent Development
11.13 cells4life
11.13.1 cells4life Company Detail
11.13.2 cells4life Business Overview
11.13.3 cells4life Cord Blood Registry Introduction
11.13.4 cells4life Revenue in Cord Blood Registry Business (2018-2023)
11.13.5 cells4life Recent Development
11.14 Beikebiotech
11.14.1 Beikebiotech Company Detail
11.14.2 Beikebiotech Business Overview
11.14.3 Beikebiotech Cord Blood Registry Introduction
11.14.4 Beikebiotech Revenue in Cord Blood Registry Business (2018-2023)
11.14.5 Beikebiotech Recent Development
11.15 StemCyte
11.15.1 StemCyte Company Detail
11.15.2 StemCyte Business Overview
11.15.3 StemCyte Cord Blood Registry Introduction
11.15.4 StemCyte Revenue in Cord Blood Registry Business (2018-2023)
11.15.5 StemCyte Recent Development
11.16 Cellsafe Biotech Group
11.16.1 Cellsafe Biotech Group Company Detail
11.16.2 Cellsafe Biotech Group Business Overview
11.16.3 Cellsafe Biotech Group Cord Blood Registry Introduction
11.16.4 Cellsafe Biotech Group Revenue in Cord Blood Registry Business (2018-2023)
11.16.5 Cellsafe Biotech Group Recent Development
11.17 PacifiCord
11.17.1 PacifiCord Company Detail
11.17.2 PacifiCord Business Overview
11.17.3 PacifiCord Cord Blood Registry Introduction
11.17.4 PacifiCord Revenue in Cord Blood Registry Business (2018-2023)
11.17.5 PacifiCord Recent Development
11.18 Americord
11.18.1 Americord Company Detail
11.18.2 Americord Business Overview
11.18.3 Americord Cord Blood Registry Introduction
11.18.4 Americord Revenue in Cord Blood Registry Business (2018-2023)
11.18.5 Americord Recent Development
11.19 Krio
11.19.1 Krio Company Detail
11.19.2 Krio Business Overview
11.19.3 Krio Cord Blood Registry Introduction
11.19.4 Krio Revenue in Cord Blood Registry Business (2018-2023)
11.19.5 Krio Recent Development
11.20 Familycord
11.20.1 Familycord Company Detail
11.20.2 Familycord Business Overview
11.20.3 Familycord Cord Blood Registry Introduction
11.20.4 Familycord Revenue in Cord Blood Registry Business (2018-2023)
11.20.5 Familycord Recent Development
11.21 Cryo Stemcell
11.21.1 Cryo Stemcell Company Detail
11.21.2 Cryo Stemcell Business Overview
11.21.3 Cryo Stemcell Cord Blood Registry Introduction
11.21.4 Cryo Stemcell Revenue in Cord Blood Registry Business (2018-2023)
11.21.5 Cryo Stemcell Recent Development
11.22 Stemade Biotech
11.22.1 Stemade Biotech Company Detail
11.22.2 Stemade Biotech Business Overview
11.22.3 Stemade Biotech Cord Blood Registry Introduction
11.22.4 Stemade Biotech Revenue in Cord Blood Registry Business (2018-2023)
11.22.5 Stemade Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’